MSB 10.4% $1.49 mesoblast limited

Previous FDA submissions had the short positions significant, it...

  1. 145 Posts.
    lightbulb Created with Sketch. 75
    Previous FDA submissions had the short positions significant, it appeared as though" loose lips were at play" and they got it right as they seem to do. On this FDA submission short positions are very low, should we read into this? the only noise is from anonymous HC emotionally charged critics.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.